Skip to main content
. 2022 Jul 28;27(30):2100809. doi: 10.2807/1560-7917.ES.2022.27.30.2100809

Table 2. Characteristics of migrants living with HIV, diagnosed before or after immigration, stratified by calendar periods, Denmark, 1995–2020 (n = 2,166).

Characteristics Calendar period
1995–99
n = 394
2000–04
n = 414
2005–09
n = 426
2010–14
n = 456
2015–20
n = 476
n % n % n % n % n %
Diagnosed after immigration (n = 1,514) 308 78 316 76 317 74 291 64 282 59
Age in years, median (IQR) 33 (28–38) 32 (29 – 38) 35 (28–41) 35 (30–41) 33 (28–41)
Sexa Males 154 50 150 47 164 52 170 58 192 68
Females 154 50 166 53 153 48 121 42 88 31
Region of origin Sub-Saharan Africa 161 52 169 53 137 43 108 37 80 28
Western Countries 57 19 46 15 46 15 55 19 46 16
East and South Asia 45 15 63 20 71 22 58 20 56 20
Eastern Europe 5 2 12 4 27 9 36 12 48 17
Other 40 13 26 8 36 11 34 12 52 18
Reported HIV transmission modes Sex between men 54 18 54 17 76 24 92 32 112 40
Sex between men and women 215 70 224 71 199 63 154 53 81 29
Injecting drug use 11 4 17 5 9 3 10 3 ≤ 4 ≤ 1
Other/unknown 28 9 21 7 33 10 35 12 86 30
HIV-RNA valuesb HIV-RNA measurement at LTC 185 60 306 97 294 93 284 98 266 94
HIV-RNA (log10 copies/ml), median (IQR) 4.6 (3.9–5.2) 4.7 (4.1 – 5.3) 4.5 (3.7–5.1) 4.7 (4.0–5.3) 4.7 (3.8–5.3)
HIV-RNA < 200 copies/ml 5 3 12 4 13 4 19 7 29 11
CD4+ T-cell countsb CD4+ T-cell count at LTC 294 95 307 97 289 91 285 98 246 87
CD4+ T-cell count (cells/µL), median (IQR)c 253 (95–400) 220 (89–440) 310 (163–441) 334 (152–524) 330 (179–502)
Late-stage HIV Late presentersd 197 67 205 67 168 58 151 53 135 55
Advanced HIV diseasee 124 42 147 48 91 31 98 34 70 28
AIDS 45 15 47 15 38 12 33 11 12 12
Diagnosed before immigration (n = 652) 86 22 98 24 109 26 165 36 194 41
Age in years, median (IQR) 32 (28–38) 31 (26–37) 35 (30–41) 34 (28–41) 33 (29–41)
Sex Males 39 45 36 37 62 57 101 61 123 63
Females 47 55 62 63 47 43 64 39 71 37
Region of origin Sub-Saharan Africa 46 53 48 49 43 39 55 33 44 23
Western Countries 21 24 19 19 34 31 51 31 71 37
East and South Asia 15 17 24 24 14 13 28 17 29 15
Eastern Europe ≤ 4 ≤ 5 ≤ 4 ≤ 4 5 5 17 10 19 10
Other ≤ 4 ≤ 5 6 6 13 12 14 8 31 16
Reported HIV transmission modes Sex between men 20 23 18 18 41 38 63 38 60 31
Sex between men and women 51 59 69 70 61 56 56 34 42 22
Injecting drug use ≤ 4 ≤ 5 ≤ 4 ≤ 4 5 5 7 4 ≤ 4 ≤ 2
Other/unknown 11 13 7 7 ≤ 4 ≤ 4 39 24 92 47
HIV-RNA valuesf HIV-RNA measurement at LTC 53 62 85 87 97 89 151 92 181 93
HIV-RNA (log10 copies/ml), median (IQR) 4.3 (2.8–5.1) 4.4 (3.4–5.0) 2.6 (1.6–4.3) 1.9 (1.3–4.4) 1.3 (1.3–1.5)
HIV-RNA < 200 copies/ml 6 11 10 12 45 46 84 56 151 83
CD4+ T-cell countsf CD4+ T-cell count at LTC 74 86 93 94 93 85 148 90 145 75
CD4+ T-cell count (cells/µL), median (IQR)c 270 (133–488) 262 (128–472) 376 (224–560) 435 (290–603) 600 (446–774)
Late-stage HIV CD4+ T-cell  < 350 cells/µL/AIDSf 44 59 57 61 40 43 58 39 19 13
CD4+ T-cell  < 200 cells/µL/AIDSf 28 38 35 38 21 23 30 20 8 6
AIDS 10 12 14 14 6 6 12 7 6 3

AIDS: acquired immunodeficiency syndrome; IQR: interquartile range; LTC: linkage to care; NA: not applicable.

All characteristics were collected at date of LTC.

a Missing information on sex on ≤ 4 (≤ 0.2%) in 2015–20.

b Data were missing for some MLWH for the following variables: HIV-RNA (n = 179) and CD4+ T-cell count (n = 93) and were excluded from analyses of HIV-RNA, CD4+ T-cell count and late presentation/advanced HIV disease.

c CD4+ T-cell normal range: 500–1,500 cells/µl.

d Presenting with CD4+ T-cell count < 350 cells/µl or with an AIDS-defining event regardless of CD4+ T-cell count.

e Presenting with CD4+ T-cell count < 200 cells/µl or with an AIDS-defining event regardless of CD4+ T-cell count.

f Data were missing for some MLWH for the following variables: HIV-RNA (n = 85) and CD4+ T-cell count (n = 99) and were excluded from analyses of HIV-RNA and CD4+ T-cell count.